SoftBank Backs Dog DNA Startup Embark at $700 Million Valuation

Softbank Group Corp.’s Vision Fund 2 led a $75 million funding round for Embark Veterinary Inc., a genetics startup that seeks to increase dog lifespans.

The transaction values the Boston-based company at $700 million, Embark Chief Executive Officer Ryan Boyko said in an interview.

“We give pet owners and breeders tools to create the best future for their dogs and want to be able to expand our audience,” Boyko said, noting that Embark plans to use the proceeds for hiring and product development. “The topic of mortality, because of the pandemic, has made families realize they want their dogs around ...